NASDAQ:VRAY ViewRay (VRAY) Stock Price, News & Analysis → Charles Payne Demystifies Options (From Unstoppable Prosperity) (Ad) Free VRAY Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range N/A50-Day Range$0.03▼$0.6552-Week Range N/AVolume108.50 million shsAverage Volume7.51 million shsMarket Capitalization$4.59 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get ViewRay alerts: Email Address Ad Unstoppable ProsperityCharles Payne Demystifies OptionsWhen it comes to retirement, everyone fears one thing… Outliving their retirement savings. You'll discover conservative, beginner-friendly options strategies which could help to cash flow your stock portfolio. Click here to register for free. About ViewRay Stock (NASDAQ:VRAY)ViewRay, Inc. designs, manufactures, and markets magnetic resonance imaging (MRI) guided radiation therapy systems to image and treat cancer patients in the United States, Italy, France, Taiwan, the United Kingdom, and internationally. It provides MRIdian, which is an MRI guided radiation therapy system that addresses beam distortion, skin toxicity, and other concerns. The company serves university research and teaching hospitals, community hospitals, private practices, government institutions, and freestanding cancer centers through a network of direct sales force and distributors. ViewRay, Inc. was founded in 2004 and is headquartered in Denver, Colorado.Read More Ad Unstoppable ProsperityCharles Payne Demystifies OptionsWhen it comes to retirement, everyone fears one thing… Outliving their retirement savings. You'll discover conservative, beginner-friendly options strategies which could help to cash flow your stock portfolio. Click here to register for free. VRAY Stock News HeadlinesMarch 16, 2024 | finance.yahoo.comVRAY Jan 2025 2.000 callMarch 16, 2024 | finance.yahoo.comVRAY Jan 2025 0.500 putMay 11, 2024 | Banyan Hill Publishing (Ad)The Best AI Stock to Own in the World Today is Trading for Just $25“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet.March 16, 2024 | finance.yahoo.comVRAY Jan 2025 0.500 callMarch 16, 2024 | finance.yahoo.comVRAY Jan 2025 3.000 putNovember 4, 2023 | morningstar.comViewRay Inc VRAYQNovember 1, 2023 | benzinga.comNUBURU Appoints Brian Knaley as new CEOOctober 19, 2023 | tmcnet.comOpen Letter to ViewRay Customers, Service, Software Engineers and Suppliers-Let's Preserve ViewRay TechnologyMay 11, 2024 | Banyan Hill Publishing (Ad)The Best AI Stock to Own in the World Today is Trading for Just $25“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet.October 17, 2023 | benzinga.comLetter to ViewRay Lenders/Investment Bankers and Customers From Krishnan Suthanthiran, President/Founder of TeamBest Global CompaniesAugust 20, 2023 | ca.finance.yahoo.comViewRay Inc (6L9.BE)July 21, 2023 | seekingalpha.comViewRay stock to be delisted from Nasdaq and moved to OTC ExchangeJuly 21, 2023 | finance.yahoo.comViewRay® Announces Commencement of Nasdaq Delisting Proceedings: Common Stock Expected to Begin Trading on the OTC MarketsJuly 18, 2023 | benzinga.comWhy ViewRay Stock Hit A New 52-Week Low TodayJuly 18, 2023 | finanznachrichten.deViewRay, Inc.: ViewRay Files Voluntary Chapter 11 PetitionsJuly 17, 2023 | msn.comWhy ViewRay (VRAY) Stock Hit A New 52-Week Low TodayJuly 17, 2023 | investorplace.comWhy Is ViewRay (VRAY) Stock Down 69% Today?July 17, 2023 | finance.yahoo.comViewRay® Files Voluntary Chapter 11 PetitionsJuly 7, 2023 | msn.comViewRay: Near-Term Bankruptcy Filing Might Be In The Cards - SellMay 26, 2023 | fool.comViewRay (NASDAQ: VRAY)May 25, 2023 | markets.businessinsider.comViewray (VRAY) Receives a Hold from Stifel NicolausMay 16, 2023 | finance.yahoo.comDo You Believe in the Growth Prospects of ViewRay (VRAY)?May 13, 2023 | msn.comMorgan Stanley Maintains ViewRay (VRAY) Equal-Weight RecommendationMay 12, 2023 | finance.yahoo.comNeed To Know: The Consensus Just Cut Its ViewRay, Inc. (NASDAQ:VRAY) Estimates For 2023May 12, 2023 | finance.yahoo.comViewRay's MRIdian® to be Featured at Leading European Radiation Oncology MeetingMay 11, 2023 | finanznachrichten.deViewRay, Inc.: ViewRay Announces First Quarter 2023 ResultsMay 11, 2023 | markets.businessinsider.comB.Riley Financial downgrades Viewray (VRAY) to a HoldSee More Headlines Receive VRAY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for ViewRay and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings2/27/2023Today5/11/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Electromedical equipment Sub-IndustryN/A Current SymbolNASDAQ:VRAY CUSIPN/A CIK1597313 Webwww.viewray.com Phone(440) 703-3210Fax800-417-3459Employees295Year Founded2004Price Target and Rating Average Stock Price Target$0.00 High Stock Price Target$0.00 Low Stock Price Target$10,000,000.00 Consensus RatingHold Rating Score (0-4)2.00 Research Coverage0 Analysts Profitability EPS (Most Recent Fiscal Year)($0.60) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-107,330,000.00 Net Margins-104.30% Pretax Margin-104.30% Return on Equity-120.48% Return on Assets-42.39% Debt Debt-to-Equity RatioN/A Current Ratio1.16 Quick Ratio0.91 Sales & Book Value Annual Sales$105.86 million Price / Sales0.00 Cash FlowN/A Price / Cash FlowN/A Book Value$0.45 per share Price / BookN/AMiscellaneous Outstanding Shares183,402,000Free Float178,817,000Market Cap$4.59 million OptionableOptionable Beta0.81 Social Links 7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed InvestorsAs the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.Get This Free Report Key ExecutivesMr. Scott William Drake (Age 55)Pres, CEO & Director Comp: $1.8MMr. Robert S. McCormack J.D. (Age 56)Chief Legal Officer Comp: $692.36kDr. James F. Dempsey Ph.D. (Age 52)Founder & Chief Scientific Officer Mr. William P. Burke (Age 54)Exec. VP & CFO Drew HillSr. VP of Operations & Devel.Matt HarrisonDirector of Investor RelationsKaren HackstaffVP of MarketingMr. Robert Michael Fuchs (Age 56)Chief HR Officer Dr. Martin Fuss M.D.Ph.D., Chief Medical OfficerMr. Paul Ziegler Jr. (Age 49)J.D., Exec. VP & Chief Commercial Officer More ExecutivesKey CompetitorsENDRA Life SciencesNASDAQ:NDRANuwellisNASDAQ:NUWEHelius Medical TechnologiesNASDAQ:HSDTTivic Health SystemsNASDAQ:TIVCBioSig TechnologiesNASDAQ:BSGMView All CompetitorsInsidersSanket ShahSold 30,364 sharesTotal: $2,125.48 ($0.07/share)Karen PrangeSold 37,600 sharesTotal: $1,880.00 ($0.05/share)Farhad Fred EbrahimiSold 8,203,610 sharesTotal: $492,216.60 ($0.06/share)Paul Ziegler JrSold 169,785 sharesTotal: $11,884.95 ($0.07/share)B Kristine JohnsonSold 79,622 sharesTotal: $5,573.54 ($0.07/share) VRAY Stock Analysis - Frequently Asked Questions How were ViewRay's earnings last quarter? ViewRay, Inc. (NASDAQ:VRAY) announced its earnings results on Monday, February, 27th. The company reported ($0.15) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.16) by $0.01. The company earned $34.70 million during the quarter, compared to analyst estimates of $34.65 million. ViewRay had a negative net margin of 104.30% and a negative trailing twelve-month return on equity of 120.48%. The firm's quarterly revenue was up 70.1% compared to the same quarter last year. During the same period in the previous year, the business posted ($0.16) earnings per share. What is Scott Drake's approval rating as ViewRay's CEO? 5 employees have rated ViewRay Chief Executive Officer Scott Drake on Glassdoor.com. Scott Drake has an approval rating of 59% among the company's employees. This puts Scott Drake in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies. What other stocks do shareholders of ViewRay own? Based on aggregate information from My MarketBeat watchlists, some companies that other ViewRay investors own include Alibaba Group (BABA), Amarin (AMRN), Sorrento Therapeutics (SRNE), TherapeuticsMD (TXMD), Verastem (VSTM), Corbus Pharmaceuticals (CRBP), Viking Therapeutics (VKTX), AbbVie (ABBV), Accuray (ARAY) and Selecta Biosciences (SELB). When did ViewRay IPO? ViewRay (VRAY) raised $52 million in an initial public offering on the week of April 6th 2015. The company issued 4,000,000 shares at a price of $12.00-$14.00 per share. Cowen and Company and Stifel served as the underwriters for the IPO and BTIG and Brean Capital were co-managers. Does ViewRay have any subsidiaries? The following companies are subsidiares of ViewRay: Vesuvius Acquisition Corp., ViewRay GmbH, and ViewRay Technologies Inc..Read More This page (NASDAQ:VRAY) was last updated on 5/11/2024 by MarketBeat.com Staff From Our PartnersHe Is Giving Away BitcoinCrypto Swap ProfitsThe Crypto 9-5 Escape PlanCrypto 101 MediaThe A.I. story nobody is telling you (Read ASAP)TradeSmithObama’s Forever Term [exposed]Porter & CompanyCharles Payne Demystifies OptionsUnstoppable ProsperityDems have chosen Biden replacement?Paradigm PressForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingBill Clinton Backing Biden Replacement???The Freeport Society Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ViewRay, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.